Adaptive Biotechnologies Corp

Healthcare · Diagnostics & Research

29.80$ +5.3% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

Adaptive Biotechnologies Corp (ADPT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 641 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ADPT
Line item	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	0.0	–	–	333	615	601	917	912	875	855	1,095	1,116	1,072	1,033	993	923	858	807	884	857	791	765	718	661	620	585	559	539	511	497	491	513	506	641
Current Assets	192	–	–	181	459	442	601	613	585	600	877	727	765	644	467	403	419	439	564	562	501	477	435	410	374	352	308	284	256	262	281	300	292	421
Cash	-192	–	–	55	111	48	75	97	213	365	497	123	174	184	122	139	115	76	218	90	95	109	89	65	71	60	38	48	51	43	55	70	78	170
Cash & Short-Term Investments	192	–	–	165	440	423	573	577	555	570	835	688	714	598	415	353	364	384	508	498	441	417	371	346	309	292	243	222	193	198	213	227	218	344
Receivables	0.0	–	–	4.8	4.1	7.3	9.3	13	9.4	7.9	12	10	20	14	17	17	23	24	27	40	31	32	31	38	42	36	41	42	44	44	46	50	48	50
Inventory	0.0	–	–	7.8	7.9	8.0	8.7	9.1	11	11	11	14	17	19	18	19	21	19	17	14	20	19	19	14	13	13	12	8.4	8.7	8.4	9.9	9.8	11	10
Property, Plant & Equipment	0.0	–	–	–	21	22	47	24	56	64	69	40	56	167	88	85	86	87	87	83	81	–	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	0.0	–	–	119	119	119	119	119	119	119	119	119	119	119	119	119	119	119	119	119	119	119	119	119	119	119	119	119	119	119	119	119	119	119
Intangible Assets	0.0	–	–	14	13	13	12	12	12	11	11	10	9.8	9.4	9.0	8.5	8.1	7.7	7.3	6.8	6.4	6.0	5.6	5.1	4.7	4.3	3.9	3.4	3.0	2.6	2.2	1.7	1.3	0.9
Total Liabilities	0.0	–	–	591	326	886	331	341	323	325	320	373	346	340	341	319	305	288	396	393	368	369	356	353	346	343	335	337	321	317	286	288	282	490
Current Liabilities	0.0	–	–	23	63	75	73	78	78	93	101	105	107	117	122	114	115	111	104	110	90	95	93	88	83	88	88	98	88	92	83	90	87	88
Short-Term Debt	0.0	–	–	–	0.0	–	–	–	1.5	3.2	4.0	3.5	4.3	4.8	5.1	5.1	8.5	8.6	8.5	9.2	9.3	9.3	9.5	9.4	9.6	9.8	10	10	10	10.0	9.4	14	14	8.8
Accounts Payable	0.0	–	–	1.8	3.3	2.9	2.4	4.5	3.9	3.7	5.4	3.2	5.2	6.1	8.3	3.3	6.0	2.7	4.2	8.1	6.3	9.2	4.5	7.7	12	9.9	7.4	7.3	6.4	6.9	10	6.5	9.6	5.2
Long-Term Debt	0.0	–	–	–	0.4	2.6	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	335
Shareholders' Equity	337	–	–	-258	288	-284	586	571	552	530	775	743	726	693	652	604	553	518	488	464	424	396	362	308	275	242	224	203	190	180	204	219	216	143
Retained Earnings	0.0	–	–	-296	-315	-331	-345	-365	-397	-430	-467	-512	-552	-602	-657	-719	-782	-834	-879	-919	-977	-1,025	-1,075	-1,144	-1,192	-1,238	-1,270	-1,304	-1,334	-1,359	-1,350	-1,363	-1,383	-1,423
Shares Outstanding	106	106	106	106	121	123	124	124	126	127	134	137	139	140	141	141	142	142	143	143	144	144	145	145	146	147	148	147	149	152	163	153	156	158

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings